BTCC / BTCC Square / Global Cryptocurrency /
Microsoft Advances AI-Driven Neurology Through INBRAIN Partnership

Microsoft Advances AI-Driven Neurology Through INBRAIN Partnership

Published:
2025-11-10 20:48:02
6
3
BTCCSquare news:

Microsoft's stock (NASDAQ:MSFT) climbed nearly 1.5% as the tech giant unveiled a collaboration with INBRAIN Neuroelectronics to develop next-generation brain-computer interfaces (BCIs). The partnership leverages Microsoft's agentic AI tools and Azure cloud platform to create adaptive neural therapies for conditions like Parkinson's disease and epilepsy.

INBRAIN's graphene-based neural technology, combined with Microsoft's AI ecosystem, aims to deliver real-time precision neurology. "This brings us closer to a future where brain disorders are treated with unprecedented accuracy," said INBRAIN CEO Carolina Aguilar. The initiative underscores Microsoft's strategic push into AI-powered healthcare solutions.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.